Skip to main content
A

ANTEOTECH LTD — Investor Relations & Filings

Ticker · ADO ISIN · AU000000ADO8 ASX Professional, scientific and technical activities
Filings indexed 1,278 across all filing types
Latest filing 2021-09-22 Regulatory Filings
Country AU Australia
Listing ASX ADO

About ANTEOTECH LTD

https://anteotech.com

AnteoTech Ltd is a surface chemistry company specializing in the development of proprietary nanoglue technology. The company focuses on two primary sectors: life sciences and energy. In the life sciences division, AnteoTech utilizes its AnteoBind molecular linker technology to enhance the performance of point-of-care diagnostic tests, bioprocessing, and assay development by improving the binding of biomolecules to synthetic surfaces. In the energy sector, the company develops advanced materials for lithium-ion batteries, specifically focusing on silicon anodes. Its AnteoX additive is designed to improve the electrochemical performance and structural stability of high-silicon content anodes, addressing capacity loss and cycle life challenges. The company's core value proposition lies in its ability to manipulate surface interfaces at the molecular level to optimize performance in complex chemical and biological environments.

Recent filings

Filing Released Lang Actions
InvestorStream Interview Presentation 21 pages 1.5MB
Regulatory Filings
2021-09-22 English
Change of Director's Interest Notice 2 pages 206.0KB
Regulatory Filings
2021-09-20 English
Investor Webinar Invitation 1 page 141.3KB
Regulatory Filings
2021-09-16 English
ADO secures Distribution Agreement for Greece and Cyprus 3 pages 254.9KB
Regulatory Filings
2021-09-15 English
AnteoTech Signs Turkish Distribution Agreement for EuGeni 2 pages 232.6KB
Regulatory Filings
2021-09-05 English
Initial Director's Interest Notice x 2 4 pages 164.2KB
Regulatory Filings
2021-09-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.